Literature DB >> 28424288

Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.

Caitlin M Miller1, Hisashi Akiyama2, Luis M Agosto3, Ann Emery4, Chelsea R Ettinger2, Ronald I Swanstrom5,6, Andrew J Henderson3, Suryaram Gummuluru7.   

Abstract

Viral protein R (Vpr) is an HIV-1 accessory protein whose function remains poorly understood. In this report, we sought to determine the requirement of Vpr for facilitating HIV-1 infection of monocyte-derived dendritic cells (MDDCs), one of the first cell types to encounter virus in the peripheral mucosal tissues. In this report, we characterize a significant restriction of Vpr-deficient virus replication and spread in MDDCs alone and in cell-to-cell spread in MDDC-CD4+ T cell cocultures. This restriction of HIV-1 replication in MDDCs was observed in a single round of virus replication and was rescued by the expression of Vpr in trans in the incoming virion. Interestingly, infections of MDDCs with viruses that encode Vpr mutants unable to interact with either the DCAF1/DDB1 E3 ubiquitin ligase complex or a host factor hypothesized to be targeted for degradation by Vpr also displayed a significant replication defect. While the extent of proviral integration in HIV-1-infected MDDCs was unaffected by the absence of Vpr, the transcriptional activity of the viral long terminal repeat (LTR) from Vpr-deficient proviruses was significantly reduced. Together, these results characterize a novel postintegration restriction of HIV-1 replication in MDDCs and show that the interaction of Vpr with the DCAF1/DDB1 E3 ubiquitin ligase complex and the yet-to-be-identified host factor might alleviate this restriction by inducing transcription from the viral LTR. Taken together, these findings identify a robust in vitro cell culture system that is amenable to addressing mechanisms underlying Vpr-mediated enhancement of HIV-1 replication.IMPORTANCE Despite decades of work, the function of the HIV-1 protein Vpr remains poorly understood, primarily due to the lack of an in vitro cell culture system that demonstrates a deficit in replication upon infection with viruses in the absence of Vpr. In this report, we describe a novel cell infection system that utilizes primary human dendritic cells, which display a robust decrease in viral replication upon infection with Vpr-deficient HIV-1. We show that this replication difference occurs in a single round of infection and is due to decreased transcriptional output from the integrated viral genome. Viral transcription could be rescued by virion-associated Vpr. Using mutational analysis, we show that domains of Vpr involved in binding to the DCAF1/DDB1/E3 ubiquitin ligase complex and prevention of cell cycle progression into mitosis are required for LTR-mediated viral expression, suggesting that the evolutionarily conserved G2 cell cycle arrest function of Vpr is essential for HIV-1 replication.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Vpr; dendritic cells; human immunodeficiency virus; transcription

Mesh:

Substances:

Year:  2017        PMID: 28424288      PMCID: PMC5469257          DOI: 10.1128/JVI.00051-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  118 in total

1.  Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells.

Authors:  D Dedera; W Hu; N Vander Heyden; L Ratner
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

2.  Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.

Authors:  Ferdinand Roesch; Léa Richard; Réjane Rua; Françoise Porrot; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

3.  Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses.

Authors:  M A Vodicka; W C Goh; L I Wu; M E Rogel; S R Bartz; V L Schweickart; C J Raport; M Emerman
Journal:  Virology       Date:  1997-06-23       Impact factor: 3.616

4.  HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination.

Authors:  C Nakai-Murakami; M Shimura; M Kinomoto; Y Takizawa; K Tokunaga; T Taguchi; S Hoshino; K Miyagawa; T Sata; H Kurumizaka; A Yuo; Y Ishizaka
Journal:  Oncogene       Date:  2006-09-18       Impact factor: 9.867

5.  Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes.

Authors:  Cinzia Nobile; Caroline Petit; Arnaud Moris; Katharina Skrabal; Jean-Pierre Abastado; Fabrizio Mammano; Olivier Schwartz
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex.

Authors:  Travis H Stracker; Christian T Carson; Matthew D Weitzman
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

7.  Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme.

Authors:  M Bouhamdan; S Benichou; F Rey; J M Navarro; I Agostini; B Spire; J Camonis; G Slupphaug; R Vigne; R Benarous; J Sire
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Vpr expression abolishes the capacity of HIV-1 infected cells to repair uracilated DNA.

Authors:  Patrick Eldin; Nathalie Chazal; David Fenard; Eric Bernard; Jean-François Guichou; Laurence Briant
Journal:  Nucleic Acids Res       Date:  2013-10-30       Impact factor: 16.971

9.  HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.

Authors:  Jean-Philippe Belzile; Ghislaine Duisit; Nicole Rougeau; Johanne Mercier; Andrés Finzi; Eric A Cohen
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

10.  Activation of the DNA Damage Response Is a Conserved Function of HIV-1 and HIV-2 Vpr That Is Independent of SLX4 Recruitment.

Authors:  Oliver I Fregoso; Michael Emerman
Journal:  mBio       Date:  2016-09-13       Impact factor: 7.867

View more
  16 in total

1.  Virus-Mimicking Polymer Nanoparticles Targeting CD169+ Macrophages as Long-Acting Nanocarriers for Combination Antiretrovirals.

Authors:  Behnaz Eshaghi; Josiane Fofana; Sarah B Nodder; Suryaram Gummuluru; Björn M Reinhard
Journal:  ACS Appl Mater Interfaces       Date:  2022-01-07       Impact factor: 10.383

2.  HIV-1 intron-containing RNA expression induces innate immune activation and T cell dysfunction.

Authors:  Hisashi Akiyama; Caitlin M Miller; Chelsea R Ettinger; Anna C Belkina; Jennifer E Snyder-Cappione; Suryaram Gummuluru
Journal:  Nat Commun       Date:  2018-08-27       Impact factor: 14.919

3.  Promiscuous Targeting of Cellular Proteins by Vpr Drives Systems-Level Proteomic Remodeling in HIV-1 Infection.

Authors:  Edward J D Greenwood; James C Williamson; Agata Sienkiewicz; Adi Naamati; Nicholas J Matheson; Paul J Lehner
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

4.  Infectious Virus Persists in CD4+ T Cells and Macrophages in Antiretroviral Therapy-Suppressed Simian Immunodeficiency Virus-Infected Macaques.

Authors:  Celina M Abreu; Rebecca T Veenhuis; Claudia R Avalos; Shelby Graham; Suzanne E Queen; Erin N Shirk; Brandon T Bullock; Ming Li; Kelly A Metcalf Pate; Sarah E Beck; Lisa M Mangus; Joseph L Mankowski; Janice E Clements; Lucio Gama
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

Review 5.  Illuminating the Role of Vpr in HIV Infection of Myeloid Cells.

Authors:  Sarah Beth Nodder; Suryaram Gummuluru
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

6.  HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.

Authors:  F Forouzanfar; S Ali; C Wallet; M De Rovere; C Ducloy; H El Mekdad; M El Maassarani; A Aït-Ammar; J Van Assche; E Boutant; F Daouad; F Margottin-Goguet; C Moog; C Van Lint; C Schwartz; O Rohr
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

7.  HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport.

Authors:  Hataf Khan; Rebecca P Sumner; Jane Rasaiyaah; Choon Ping Tan; Maria Teresa Rodriguez-Plata; Chris Van Tulleken; Douglas Fink; Lorena Zuliani-Alvarez; Lucy Thorne; David Stirling; Richard Sb Milne; Greg J Towers
Journal:  Elife       Date:  2020-12-10       Impact factor: 8.140

8.  HIV-1 Vpr Induces Widespread Transcriptomic Changes in CD4+ T Cells Early Postinfection.

Authors:  Hélène Bauby; Christopher C Ward; Reiner Schulz; Caroline Goujon; Michael H Malim; Rupert Hugh-White; Chad M Swanson
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.786

9.  Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex.

Authors:  Leonid Yurkovetskiy; Mehmet Hakan Guney; Kyusik Kim; Shih Lin Goh; Sean McCauley; Ann Dauphin; William E Diehl; Jeremy Luban
Journal:  Nat Microbiol       Date:  2018-10-08       Impact factor: 17.745

Review 10.  Vpr and Its Cellular Interaction Partners: R We There Yet?

Authors:  Helena Fabryova; Klaus Strebel
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.